tada you posted - "Threading a couple of sentences together from page 8 of the article: "VLDL catabolism-derived HDL particles became enriched in TG at the expense of cholesterol ester(CE) via the action of CETP. This has the net effect of driving plasma  HDL-C lower. This hinders the formation of large HDL in favour of smaller  CE-poor HDL"."

 So this is from many years ago and Dr Wong was already aware of this problem with CEPT inhibitors.

This sure gives me faith in the statement that Don always makes about RVX being 8 or 9 years ahead of the game in their medical chemistry. I was getting skeptical of the claim.

Great post. Thanks.

Toinv